von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura
- PMID: 8580019
- DOI: 10.1007/BF00860949
von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura
Abstract
levels of von Willebrand factor antigen (vWf:Ag) and factor XIII activity (F XIII) were studied in relation to the severity of clinical symptoms (scored from 0 to 3) and to immunological parameters [IgA, C3, C4, and circulating immune complexes (CIC)] in 16 children (7 males, 9 females, aged 3-11 years) with Henoch-Schonlein purpura (HSP) at presentation. vWf:Ag was increased in 7 patients, F XIII activity was decreased in 6. In all children we found high levels of IgA, while C3 and C4 levels were normal; CIC were elevated in 11. vWf:Ag correlated with clinical score and with IgA and CIC, probably as a result of immune-mediated endothelial cell damage. The haemostatic alterations observed in HSP are important for understanding the pathophysiology of the disease.
Similar articles
-
Clinical evaluation of a pasteurized factor XIII concentrate administration in Henoch-Schönlein purpura. Japanese Pediatric Group.Thromb Res. 1989 Dec 15;56(6):667-75. doi: 10.1016/0049-3848(89)90284-3. Thromb Res. 1989. PMID: 2699100 Clinical Trial.
-
Clinical significance of blood coagulation factor XIII activity in adult Henoch-Schönlein purpura.J Nippon Med Sch. 2013;80(4):268-78. doi: 10.1272/jnms.80.268. J Nippon Med Sch. 2013. PMID: 23995569
-
Activity of blood coagulation factor XIII as a prognostic indicator in patients with Henoch-Schönlein purpura. Efficacy of factor XIII substitution.Eur J Pediatr. 1987 Sep;146(5):519-23. doi: 10.1007/BF00441608. Eur J Pediatr. 1987. PMID: 3678279
-
The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch-Schönlein purpura.Pediatr Nephrol. 1990 Sep;4(5):533-41. doi: 10.1007/BF00869841. Pediatr Nephrol. 1990. PMID: 2242325 Review.
-
Henoch-Schönlein purpura with intracerebral hemorrhage.Brain Dev. 2002 Mar;24(2):115-7. doi: 10.1016/s0387-7604(02)00015-3. Brain Dev. 2002. PMID: 11891106 Review.
Cited by
-
Henoch-Schönlein purpura.Arch Dis Child. 1999 Apr;80(4):380-3. doi: 10.1136/adc.80.4.380. Arch Dis Child. 1999. PMID: 10086951 Free PMC article. Review. No abstract available.
-
Henoch-Schonlein purpura: polymorphisms in thrombophilia genes.Pediatr Nephrol. 2006 Aug;21(8):1117-21. doi: 10.1007/s00467-006-0155-x. Epub 2006 Jun 22. Pediatr Nephrol. 2006. PMID: 16791607
-
Serum level of advanced oxidation protein products (AOPPs) in patients with Henoch-Schonlein purpura and its relationship with aberrant glycosylation of IgA1 and Cosmc mRNA expression.Int J Dermatol. 2019 Sep;58(9):1092-1097. doi: 10.1111/ijd.14550. Epub 2019 Jun 27. Int J Dermatol. 2019. PMID: 31250447 Free PMC article.
-
Impaired vascular endothelium-dependent relaxation in Henoch-Schönlein purpura.Pediatr Nephrol. 2004 Feb;19(2):138-43. doi: 10.1007/s00467-003-1335-6. Epub 2003 Dec 18. Pediatr Nephrol. 2004. PMID: 14685839
-
The association between transforming growth factor-beta gene promoter C-509T polymorphism and Chinese children with Henoch-Schönlein purpura.Pediatr Nephrol. 2004 Sep;19(9):972-5. doi: 10.1007/s00467-004-1547-4. Epub 2004 Jul 15. Pediatr Nephrol. 2004. PMID: 15257453
References
MeSH terms
Substances
LinkOut - more resources
Miscellaneous